{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:36:11Z","timestamp":1792805771717,"version":"4.5.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/38\/2017"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/38\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.arcmed.2026.103384","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:00:12Z","timestamp":1771887612000},"page":"103384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptional and Pathway Level Heterogeneity in Luminal A Breast Cancer: A Framework for Precision Therapy"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3821-9319","authenticated-orcid":false,"given":"Gowrang Kasaba","family":"Manjunath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Nashier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-4059","authenticated-orcid":false,"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2026.103384_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amsu.2019.11.021","article-title":"Molecular classification of breast cancer: A retrospective cohort study","volume":"49","author":"FK","year":"2020","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0002","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: Prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0003","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/his.15032","article-title":"Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial","volume":"83","author":"Nielsen","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.arcmed.2026.103384_bib0004","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10549-019-05402-w","article-title":"Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes","volume":"178","author":"Viale","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2026.103384_bib0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","article-title":"Luminal A Breast Cancer and Molecular Assays: A Review","volume":"23","author":"Gao","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.arcmed.2026.103384_bib0006","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/jamaoncol.2017.0751","article-title":"Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy","volume":"3","author":"Zhao","year":"2017","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.arcmed.2026.103384_bib0007","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrclinonc.2013.124","article-title":"Luminal breast cancer: from biology to treatment","volume":"10","author":"Ignatiadis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0008","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12032-014-0055-z","article-title":"Luminal breast cancer classification according to proliferative indices: clinicopathological characteristics and short-term survival analysis","volume":"31","author":"Sun","year":"2014","journal-title":"Med Oncol"},{"issue":"6,Supplement 1","key":"10.1016\/j.arcmed.2026.103384_bib0009","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0007-4551(15)31216-9","article-title":"Cancer du sein luminal et apport des classifications intrins\u00e8ques mol\u00e9culaires: comment identifier les tumeurs luminales A et B en 2015?","volume":"102","author":"Franchet","year":"2015","journal-title":"Bull Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0010","article-title":"The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial","volume":"10","author":"Lammers","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.arcmed.2026.103384_bib0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/JDRNTRUHS.JDRNTRUHS_77_20","article-title":"Intrinsic subtyping of breast cancer and its relevance with clinico-pathological features and outcomes in patients from North India: a single center experience","volume":"9","author":"Harish","year":"2020","journal-title":"J Dr NTR Univ Health Sci"},{"key":"10.1016\/j.arcmed.2026.103384_bib0012","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1042\/EBC20200174","article-title":"Current and emerging estrogen receptor-targeted therapies for the treatment of breast cancer","volume":"65","author":"Haines Corinne","year":"2021","journal-title":"Essays Biochem"},{"key":"10.1016\/j.arcmed.2026.103384_bib0013","article-title":"Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer","volume":"3","author":"Bui","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcmed.2026.103384_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102624","article-title":"Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome","volume":"120","author":"Cucciniello","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.arcmed.2026.103384_bib0015","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2026.103384_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217668","article-title":"Selective degradation of FGFR1\/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1\/2 alterations","volume":"619","author":"Uemoto","year":"2025","journal-title":"Cancer Letters"},{"key":"10.1016\/j.arcmed.2026.103384_bib0017","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/bjs.10513","article-title":"Breast cancer and genomic testing","volume":"104","author":"Liedtke","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.arcmed.2026.103384_bib0018","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000509846","article-title":"Genomic Signatures in Luminal Breast Cancer","volume":"15","author":"Puppe","year":"2020","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0019","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccell.2025.01.002","article-title":"Dynamics of molecular heterogeneity in high-risk luminal breast cancer\u2014From intrinsic to adaptive subtyping","volume":"43","author":"Denkert","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.arcmed.2026.103384_bib0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/diagnostics11091555","article-title":"Breast Cancer Heterogeneity","volume":"11","author":"Fumagalli","year":"2021","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.arcmed.2026.103384_bib0021","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fmed.2017.00227","article-title":"Tumor Heterogeneity in Breast Cancer","volume":"4","author":"Turashvili","year":"2017","journal-title":"Front Med (Lausanne"},{"key":"10.1016\/j.arcmed.2026.103384_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41523-019-0116-8","article-title":"Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses","volume":"5","author":"Poudel","year":"2019","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011197","article-title":"Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions","volume":"19","author":"Wang","year":"2023","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0024","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1078-0432.CCR-16-1278","article-title":"High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial","volume":"23","author":"Nielsen","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0025","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/genes14091708","article-title":"The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience","volume":"14","author":"Dank","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-012-2143-0","article-title":"PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer","volume":"135","author":"Prat","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2026.103384_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628690","article-title":"Activation of PI3K\/AKT\/mTOR Pathway Causes Drug Resistance in Breast Cancer","volume":"12","author":"Dong","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0028","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41523-019-0126-6","article-title":"PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer","volume":"5","author":"Nixon","year":"2019","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0029","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr3605","article-title":"PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data","volume":"16","author":"Zardavas","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.61186\/ijrr.22.2.251","article-title":"Gene expression in luminal A breast cancer and its correlation with chemoradiotherapy outcome and recurrence","volume":"22","author":"Ma","year":"2024","journal-title":"Int-J-Radiat-Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/medicina60010168","article-title":"Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice","volume":"60","author":"Lopez-Gonzalez","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115228","article-title":"Identifying and managing adverse prognosis biomarkers among advanced luminal breast cancer patients: What have we learned?","volume":"217","author":"Cottu","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0033","first-page":"525","article-title":"Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?","volume":"15","author":"H\u00f6ller","year":"2023"},{"issue":"D1","key":"10.1016\/j.arcmed.2026.103384_bib0034","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets-update","volume":"41","author":"Barrett","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0036","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2026.103384_bib0037","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"issue":"D1","key":"10.1016\/j.arcmed.2026.103384_bib0038","doi-asserted-by":"crossref","first-page":"D587","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.arcmed.2026.103384_bib0039","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0040","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0041","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"10.1016\/j.arcmed.2026.103384_bib0042","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.arcmed.2026.103384_bib0043","doi-asserted-by":"crossref","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0044","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene Set Knowledge Discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"issue":"D1","key":"10.1016\/j.arcmed.2026.103384_bib0045","doi-asserted-by":"crossref","first-page":"D1016","DOI":"10.1093\/nar\/gkae1080","article-title":"Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources","volume":"53","author":"Diamant","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0046","first-page":"445","article-title":"The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology","volume":"10","author":"Huang","year":"2019","journal-title":"Systems Biology, and Chemical Genomics. Front Pharmacol"},{"issue":"D1","key":"10.1016\/j.arcmed.2026.103384_bib0047","doi-asserted-by":"crossref","first-page":"D679","DOI":"10.1093\/nar\/gkad960","article-title":"WikiPathways 2024: next generation pathway database","volume":"52","author":"Agrawal","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0048","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-025-08592-0","article-title":"A compendium of human gene functions derived from evolutionary modelling","volume":"640","author":"Feuermann","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2026.103384_bib0049","doi-asserted-by":"crossref","DOI":"10.1038\/npre.2007.1311.1","article-title":"The NCI-Nature Pathway Interaction Database: A cell signaling resource","author":"Krupa","year":"2007","journal-title":"Nat Prec"},{"issue":"D1","key":"10.1016\/j.arcmed.2026.103384_bib0050","doi-asserted-by":"crossref","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","article-title":"DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms","volume":"52","author":"Cannon","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0051","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","author":"Gyorffy","year":"2024","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0052","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4629419","article-title":"Multiomics Integrated Analysis Identifies SLC24A2 as a Potential Link between Type 2 Diabetes and Cancer","volume":"2022","author":"Bian","year":"2022","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0053","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.molonc.2014.03.017","article-title":"Breast cancer prognosis predicted by nuclear receptor-coregulator networks","volume":"8","author":"Doan","year":"2014","journal-title":"Mol Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.935860","article-title":"COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer","volume":"13","author":"Luo","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.arcmed.2026.103384_bib0055","article-title":"Lipid metabolism associated PLPP4 gene drives oncogenic and adipogenic potential in breast cancer cells","volume":"1870","author":"Soni","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.arcmed.2026.103384_bib0056","article-title":"High expression of KIF26B in breast cancer associates with poor prognosis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2026.103384_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11083","article-title":"High expression COL10A1 promotes breast cancer progression and predicts poor prognosis","volume":"8","author":"Zhou","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.arcmed.2026.103384_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/or.2025.1516409","article-title":"A new insight into the impact of copy number variations on cell cycle deregulation of luminal-type breast cancer","volume":"19","author":"Mahdi Khamaneh","year":"2025","journal-title":"Oncol Rev"},{"key":"10.1016\/j.arcmed.2026.103384_bib0059","first-page":"246","article-title":"Exploring the Role of Seven Key Genes in Breast Cancer: Insights from In Silico and In Vitro Analyses","volume":"23","author":"Mehta","year":"2024","journal-title":"Gene Expression"},{"key":"10.1016\/j.arcmed.2026.103384_bib0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12957-020-02042-z","article-title":"Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis","volume":"18","author":"Jia","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0061","article-title":"Identifying Breast Cancer-Related Genes Based on a Novel Computational Framework Involving KEGG Pathways and PPI Network Modularity","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.arcmed.2026.103384_bib0062","article-title":"Identifying breast cancer subtypes associated modules and biomarkers by integrated bioinformatics analysis","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.arcmed.2026.103384_bib0063","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0064","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jb\/mvae079","article-title":"Cellular senescence: mechanisms and relevance to cancer and aging","volume":"177","author":"Yamauchi","year":"2024","journal-title":"J Biochem"},{"key":"10.1016\/j.arcmed.2026.103384_bib0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41419-024-07204-5","article-title":"Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2\/4 inhibition","volume":"15","author":"Vora","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.arcmed.2026.103384_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2022.11.007","article-title":"Chapter One - Exploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer","volume":"135","author":"Zarneshan","year":"2023","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0067","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death and Diff"},{"key":"10.1016\/j.arcmed.2026.103384_bib0068","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2026.103384_bib0069","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2026.103384_bib0070","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and Letrozole in Advanced Breast Cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2026.103384_bib0071","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor","volume":"6","author":"Copp\u00e9","year":"2008","journal-title":"PLOS Biology"},{"key":"10.1016\/j.arcmed.2026.103384_bib0072","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ncb2784","article-title":"A complex secretory program orchestrated by the inflammasome controls paracrine senescence","volume":"15","author":"Acosta","year":"2013","journal-title":"Nature Cell Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0073","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrd.2017.116","article-title":"Senescent cells: an emerging target for diseases of ageing","volume":"16","author":"Childs","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.arcmed.2026.103384_bib0074","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/1878-0261.13541","article-title":"CDK4\/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents","volume":"18","author":"Lee","year":"2024","journal-title":"Mol Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0075","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0076","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108946","article-title":"Pharmacological CDK4\/6 inhibition reveals a p53-dependent senescent state with restricted toxicity","volume":"41","author":"Wang","year":"2022","journal-title":"EMBO J"},{"key":"10.1016\/j.arcmed.2026.103384_bib0077","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.7150\/jca.54699","article-title":"Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy","volume":"12","author":"Huang","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0078","article-title":"Modulation of redox homeostasis: A strategy to overcome cancer drug resistance","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0079","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrgentox.2008.09.017","article-title":"Oxidative stress in environmental-induced carcinogenesis","volume":"674","author":"Mena","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.112092","article-title":"Estrogen-induced reactive oxygen species, through epigenetic reprogramming, causes increased growth in breast cancer cells","volume":"579","author":"Roy","year":"2024","journal-title":"Mol Cell Endocrinol"},{"issue":"2 Pt A","key":"10.1016\/j.arcmed.2026.103384_bib0081","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2014.04.018","article-title":"Estrogen metabolism and breast cancer","volume":"356","author":"Samavat","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2026.103384_bib0082","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12964-024-01583-0","article-title":"Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers","volume":"22","author":"Bukato","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.arcmed.2026.103384_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0084","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fonc.2019.00480","article-title":"Breast Cancer Subtypes Present a Differential Production of Reactive Oxygen Species (ROS) and Susceptibility to Antioxidant Treatment","volume":"9","author":"Sarmiento-Salinas","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1397352","article-title":"Inside the genome: understanding genetic influences on oxidative stress","volume":"15","author":"Krishnamurthy","year":"2024","journal-title":"Front Genet"},{"key":"10.1016\/j.arcmed.2026.103384_bib0086","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212387","article-title":"Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species","volume":"25","author":"Ju","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2026.103384_bib0087","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/biom9110735","article-title":"Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.arcmed.2026.103384_bib0088","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1111\/febs.16110","article-title":"Regulation of redox signaling in HIF-1-dependent tumor angiogenesis","volume":"289","author":"Manuelli","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.arcmed.2026.103384_bib0089","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.3390\/ijms21175983","article-title":"Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression","volume":"21","author":"Wei","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2026.103384_bib0090","first-page":"276","article-title":"Insights into the key roles of proteoglycans in breast cancer biology and translational medicine","volume":"1855","author":"Theocharis","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2026.103384_bib0091","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.569377","article-title":"Proteoglycans as Mediators of Cancer Tissue Mechanics","volume":"8","author":"Barkovskaya","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/j.arcmed.2026.103384_bib0092","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fcell.2020.00749","article-title":"The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis","volume":"8","author":"Ahrens","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0093","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.3390\/cancers15153813","article-title":"Effects of Hyaluronan on Breast Cancer Aggressiveness","volume":"15","author":"Parnigoni","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0094","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1172154","article-title":"A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.arcmed.2026.103384_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1038121","article-title":"SIRT1, a novel transcriptional downstream target of CD44, linking its deacetylase activity to tumor cell invasion\/metastasis","volume":"12","author":"Ahmad","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0096","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41419-019-2034-y","article-title":"Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer","volume":"10","author":"Chokchaitaweesuk","year":"2019","journal-title":"Cell Death Disease"},{"key":"10.1016\/j.arcmed.2026.103384_bib0097","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41419-020-03037-0","article-title":"CD44\/HA signaling mediates acquired resistance to a PI3Kalpha inhibitor","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.arcmed.2026.103384_bib0098","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115812","article-title":"The Hyaluronan\/CD44 Axis: A Double-Edged Sword in Cancer","volume":"24","author":"Cirillo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2026.103384_bib0099","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fphys.2017.00577","article-title":"Development and Growth of the Avian Pectoralis Major (Breast) Muscle: Function of Syndecan-4 and Glypican-1 in Adult Myoblast Proliferation and Differentiation","volume":"8","author":"Velleman","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.RES.0000159708.71142.c8","article-title":"Syndecans: new kids on the signaling block","volume":"96","author":"Tkachenko","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0101","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/febs.12168","article-title":"The heparanase\/syndecan-1 axis in cancer: mechanisms and therapies","volume":"280","author":"Ramani","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.arcmed.2026.103384_bib0102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000080280","article-title":"Prognostic value of syndecan-1 expression in breast cancer","volume":"67","author":"Leivonen","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.arcmed.2026.103384_bib0103","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/796052","article-title":"Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication","volume":"2015","author":"Szatmari","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.arcmed.2026.103384_bib0104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12885-021-07860-2","article-title":"Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Jiang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0105","first-page":"2569","article-title":"Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression","volume":"18","author":"HR","year":"2024","journal-title":"Mol Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0106","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12885-018-4441-3","article-title":"Mechanisms of immune evasion in breast cancer","volume":"18","author":"Bates","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0107","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/glycob\/cwy003","article-title":"Keratan sulfate, a complex glycosaminoglycan with unique functional capability","volume":"28","author":"Caterson","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.arcmed.2026.103384_bib0108","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.3390\/molecules25204606","article-title":"Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer","volume":"25","author":"Abdalla","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.arcmed.2026.103384_bib0109","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1101\/gad.1709008","article-title":"PPARgamma and C\/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale","volume":"22","author":"Lefterova","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.arcmed.2026.103384_bib0110","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13552","article-title":"An intronic enhancer of Cebpa regulates adipocyte differentiation and adipose tissue development via long-range loop formation","volume":"57","author":"Li","year":"2024","journal-title":"Cell Prolif"},{"key":"10.1016\/j.arcmed.2026.103384_bib0111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4331\/wjbc.v6.i2.39","article-title":"Adipocyte activation of cancer stem cell signaling in breast cancer","volume":"6","author":"Wolfson","year":"2015","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.arcmed.2026.103384_bib0112","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1091\/mbc.E19-11-0628","article-title":"beta-actin contributes to open chromatin for activation of the adipogenic pioneer factor CEBPA during transcriptional reprograming","volume":"31","author":"MA","year":"2020","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.arcmed.2026.103384_bib0113","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/537865","article-title":"PPARG in Human Adipogenesis: Differential Contribution of Canonical Transcripts and Dominant Negative Isoforms","volume":"2014","author":"Aprile","year":"2014","journal-title":"PPAR Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0114","first-page":"1","article-title":"Control of Adipocyte Differentiation in Different Fat Depots;Implications for","volume":"6","author":"Ma","year":"2015","journal-title":"Pathophysiology or Therapy. Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0115","doi-asserted-by":"crossref","first-page":"e00677","DOI":"10.1128\/MCB.00677-17","article-title":"Peroxisome Proliferator-Activated Receptor \u03b3 and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization","volume":"38","author":"Wang","year":"2018","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0116","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1128\/MCB.01344-13","article-title":"Peroxisome Proliferator-Activated Receptor \u03b3 and C\/EBP\u03b1 Synergistically Activate Key Metabolic Adipocyte Genes by Assisted Loading","volume":"34","author":"Madsen","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0117","doi-asserted-by":"crossref","first-page":"e00601","DOI":"10.1128\/MCB.00601-18","article-title":"Transcriptional and Epigenomic Regulation of Adipogenesis","volume":"39","author":"Lee","year":"2019","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0118","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/cells12162061","article-title":"The Role of Obesity in Breast Cancer Pathogenesis","volume":"12","author":"Glassman","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2026.103384_bib0119","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, Diabetes, and Increased Cancer Progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.arcmed.2026.103384_bib0120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/cells8080857","article-title":"The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update","volume":"8","author":"Chu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2026.103384_bib0121","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1940-6207.CAPR-12-0365","article-title":"PPARgamma agonists target aromatase via both PGE2 and BRCA1","volume":"5","author":"Margalit","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116095","article-title":"PPARgamma antagonists induce aromatase transcription in adipose tissue cultures","volume":"222","author":"Ardenkjaer-Skinnerup","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0123","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34113-3","article-title":"Adipose tissue dysfunction is associated with low levels of the novel Palmitic Acid Hydroxystearic Acids","volume":"8","author":"Hammarstedt","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.arcmed.2026.103384_bib0124","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2009.013797","article-title":"Role of the PI3K\/AKT and mTOR signaling pathways in acute myeloid leukemia","volume":"95","author":"Park","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.arcmed.2026.103384_bib0126","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fendo.2018.00758","article-title":"Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment","volume":"9","author":"Mentoor","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0127","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13046-020-01666-z","article-title":"Cancer-associated adipocytes: emerging supporters in breast cancer","volume":"39","author":"Zhao","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0128","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","article-title":"Adipose tissue and adipocytes support tumorigenesis and metastasis","volume":"1831","author":"Nieman","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2026.103384_bib0129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphys.2013.00275","article-title":"Adipose tissue immunity and cancer","volume":"4","author":"Catalan","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0130","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.7150\/jca.16884","article-title":"Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation","volume":"7","author":"Divella","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0131","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0132","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cancers12092623","article-title":"The Role of PPARgamma Ligands in Breast Cancer: From Basic Research to Clinical Studies","volume":"12","author":"Augimeri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0133","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/cancers13092153","article-title":"PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis","volume":"13","author":"Cheng","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0134","doi-asserted-by":"crossref","first-page":"348","DOI":"10.31083\/j.fbl2812348","article-title":"Fatty Acid Metabolism: A New Perspective in Breast Cancer Precision Therapy","volume":"28","author":"He","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2015","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.arcmed.2026.103384_bib0136","article-title":"Artificial intelligence streamlines scientific discovery of drug-target interactions","author":"Yang","year":"2025","journal-title":"Br J Pharmacol"},{"issue":"Supplement 1","key":"10.1016\/j.arcmed.2026.103384_bib0137","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1182\/blood-2024-204155","article-title":"Combination with Ixazomib, Lenalidomide, and Dexamethasone for Relapsed and Refractory Multiple Myeloma","volume":"144","author":"Vogl","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2026.103384_bib0138","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-001803","article-title":"High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis","volume":"11","author":"Miura","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0139","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1038\/s41598-021-83494-5","article-title":"Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study","volume":"11","author":"Saito","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2026.103384_bib0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11883-024-01196-5","article-title":"The Effects of FABP4 on Cardiovascular Disease in the Aging Population","volume":"26","author":"van der Ark-Vonk","year":"2024","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.arcmed.2026.103384_bib0141","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5551\/jat.48710","article-title":"Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases","volume":"26","author":"Furuhashi","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.arcmed.2026.103384_bib0142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13041-020-0551-3","article-title":"Core transcriptional regulatory circuits in prion diseases","volume":"13","author":"Kim","year":"2020","journal-title":"Mol Brain"},{"issue":"GRSB","key":"10.1016\/j.arcmed.2026.103384_bib0143","article-title":"A Comprehensive Profile of ChIP-Seq-Based PU.1\/Spi1 Target Genes in Microglia","volume":"8","author":"Satoh","year":"2014","journal-title":"Gene Regul Syst Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0144","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/ecco-jcc\/jjac033","article-title":"Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2","volume":"16","author":"Nowak","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.arcmed.2026.103384_bib0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s42003-022-03888-7","article-title":"PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development","volume":"5","author":"Zhao","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0146","article-title":"Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0147","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.802143","article-title":"Prognostic Significance of SOCS3 in Patients With Solid Tumors: A Meta-Analysis","volume":"8","author":"Zheng","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.arcmed.2026.103384_bib0148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13058-023-01676-7","article-title":"Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance","volume":"25","author":"Zheng","year":"2023","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027384","article-title":"III. IRF8 Governs Expression of Genes Involved in Innate and Adaptive Immunity in Human and Mouse Germinal Center B Cells","volume":"6","author":"Shin","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arcmed.2026.103384_bib0150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00439-020-02154-2","article-title":"Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases","volume":"139","author":"Salem","year":"2020","journal-title":"Human Genetics"},{"key":"10.1016\/j.arcmed.2026.103384_bib0151","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.881801","article-title":"SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer","volume":"12","author":"Dai","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113666","article-title":"Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells","volume":"170","author":"Uchihara","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0153","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41523-021-00324-7","article-title":"Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer","volume":"7","author":"Gyamfi","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0154","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12272-023-01473-y","article-title":"Targeting dysregulated lipid metabolism in the tumor microenvironment","volume":"46","author":"Kim","year":"2023","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.arcmed.2026.103384_bib0155","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S1470-2045(16)30272-8","article-title":"Tasquinimod treatment for prostate cancer","volume":"17","author":"Brower","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0156","first-page":"167","article-title":"A review of tasquinimod in the treatment of advanced prostate cancer","volume":"7","author":"Williamson","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.arcmed.2026.103384_bib0157","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jat.1429","article-title":"Oestrogenic activity of benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) in MCF7 human breast cancer cells in vitro","volume":"29","author":"Charles","year":"2009","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0158","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1200\/JCO.20.02755","article-title":"Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)","volume":"39","author":"Shah","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100590","article-title":"Progress and challenges in gastroesophageal cancer","volume":"44","author":"Serra","year":"2020","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/ph14050470","article-title":"Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance","volume":"14","author":"Tilija Pun","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arcmed.2026.103384_bib0161","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-015-0098-5","article-title":"Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment","volume":"3","author":"Olsson","year":"2015","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0162","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.trecan.2022.04.006","article-title":"Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy","volume":"8","author":"Witkiewicz","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.arcmed.2026.103384_bib0163","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.3390\/cancers15194689","article-title":"Estrogen Receptor Signaling in Breast Cancer","volume":"15","author":"Miziak","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0164","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.dnarep.2015.03.002","article-title":"BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication","volume":"30","author":"Fridlich","year":"2015","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0165","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202200046","article-title":"Proteoglycans in breast cancer, identification and characterization by LC-MS\/MS assisted proteomics approach: A review","volume":"17","author":"Kizhakkeppurath Kumaran","year":"2023","journal-title":"PROTEOMICS - Clinical Applications"},{"key":"10.1016\/j.arcmed.2026.103384_bib0166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.05.003","article-title":"Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy","volume":"62","author":"Gubbiotti","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0167","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/cancers12040802","article-title":"ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen","volume":"12","author":"Sieuwerts","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0168","doi-asserted-by":"crossref","DOI":"10.1016\/j.cstres.2025.100108","article-title":"Reactive oxygen species in cancer: Mechanistic insights and therapeutic innovations","volume":"30","author":"Ma","year":"2025","journal-title":"Cell Stress and Chaperones"},{"key":"10.1016\/j.arcmed.2026.103384_bib0169","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/cells14151207","article-title":"Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics","volume":"14","author":"Nigam","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2026.103384_bib0170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0171","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1217875","article-title":"The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism","volume":"14","author":"Sankofi","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2026.103384_bib0172","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jmcb\/mjy080","article-title":"SOX2 in cancer stemness: tumor malignancy and therapeutic potentials","volume":"12","author":"Mamun","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2026.103384_bib0173","doi-asserted-by":"crossref","DOI":"10.1111\/ahe.70053","article-title":"The Immunohistochemical Demonstration of the Dlx-5, HLX and TLX1 Proteins in the Bovine Gastric Compartments Throughout Prenatal Development","volume":"54","author":"Topalo\u011flu","year":"2025","journal-title":"Anatomia, Histologia, Embryologia"},{"key":"10.1016\/j.arcmed.2026.103384_bib0174","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.7150\/jca.121650","article-title":"Emerging Roles of PTTG1\/Securin in Breast Cancer","volume":"16","author":"Min","year":"2025","journal-title":"J Cancer"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092600007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092600007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T01:28:48Z","timestamp":1776562128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844092600007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":174,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S018844092600007X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103384","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptional and Pathway Level Heterogeneity in Luminal A Breast Cancer: A Framework for Precision Therapy","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103384"}}